HBK Investments’s Colgate-Palmolive CL Stock Holding History

HBK Investments’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-55,600	Closed	-$4.09M	–	677
2019 Q3	$4.09M	Buy	+55,600	New	+$4.03M	0.05%	308

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HBK Investments's CL Position: Q1 2022 in Review

HBK Investments sold out of Colgate-Palmolive (CL) in Q1 2022, closing a stake of 10,341 shares — an estimated $883K sold.

HBK Investments first reported a position in CL in Q3 2017 and held it in 4 quarters. The position peaked at $8.63M in Q3 2017. 1,632 funds tracked by Wall St. Rank hold CL as of Q1 2022.

HBK Investments reported no remaining Colgate-Palmolive position as of Q1 2022 after selling out during the quarter.
HBK Investments sold 10,341 Colgate-Palmolive shares in Q1 2022, an estimated $883K.
HBK Investments first reported a position in Colgate-Palmolive in Q3 2017 and held it in 4 quarters.
HBK Investments's Colgate-Palmolive position peaked at $8.63M in Q3 2017.
1,632 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on HBK Investments's 13F filing for Q1 2022, filed 16 May 2022.